Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, New York 14620
March 9, 2020
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | Vaccinex, Inc. |
Registration Statement on Form S-3 (File No. 333-236416)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3, as amended (the Registration Statement), and declare the Registration Statement effective as of 5:00 p.m., Eastern Daylight Time, on March 11, 2020, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to William Intner of Hogan Lovells US LLP at (410) 659-2778.
Very truly yours, | ||
Vaccinex, Inc. | ||
/s/ Scott E. Royer | ||
By: | Scott E. Royer | |
Title: | Chief Financial Officer |